{
    "clinical_study": {
        "@rank": "55481", 
        "acronym": "PREFER", 
        "arm_group": {
            "arm_group_label": "Chronic obstructive pulmonary disease", 
            "description": "Patients with chronic obstructive pulmonary disease will undergo a single visit with the collection of data from his/her records."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to establish the prevalence of comorbidities in Italian\n      patients with chronic bronchitis with at least 2 exacerbations per year, and to document the\n      appropriateness of instrumental diagnostic tests, such as spirometry of these patients."
        }, 
        "brief_title": "A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is an observational study so participants will only take medication that is presently\n      prescribed by their regular healthcare provider. No additional study medication will be\n      administered. This study will enroll patients who have been previously diagnosed with COPD.\n      This study will look at the medical history and other diseases that have been diagnosed in\n      people who also have COPD.\n\n      The study will enroll approximately 3000 patients.\n\n      This multi-centre trial will be conducted in Italy. The overall time to participate in this\n      study is at a single, regularly scheduled visit at the pulmonologists office. There will not\n      be any follow up assessments."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age 45-85, of either gender.\n\n          2. Signed informed consent.\n\n          3. Known COPD documented by spirometric exams showing fixed non reversible respiratory\n             obstruction.\n\n          4. Forced Expired Volume measured after 1 second expiration (FEV-1) < 50% in a previous\n             test (no time limits).\n\n          5. Symptoms of chronic bronchitis : chronic productive cough for 3 months at least in\n             each of the 2 years prior to the index visits.\n\n          6. On treatment of bronchodilators (no restrictions) for the last 12 months at least.\n\n          7. History of at least 2 exacerbations (moderate/severe) in the last 12 months prior to\n             index visit.\n\n        Exclusion Criteria:\n\n          -  None"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "45 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with COPD will be enrolled at hospital and pulmonology departments in Italy."
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02100332", 
            "org_study_id": "RO-2455-402-IT", 
            "secondary_id": "U1111-1152-9289"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Drug Therapy", 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Veruno (Novara)", 
                    "country": "Italy"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prevalence of Comorbidities of COPD in the Exacerbator Phenotype - A Cross Sectional Disease/Condition Focused Observational Study on COPD", 
        "overall_contact": {
            "email": "medicalinformation@tpna.com", 
            "last_name": "Takeda Study Registration Call Center, 800-778-2860"
        }, 
        "overall_official": {
            "affiliation": "Takeda", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: The Italian Medicines Agency (AIFA: Agenzia Italiana del Farmaco)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The following comorbidities were accounted for (from the patient records): arterial hypertension, ischemic heart disease, other cardiac disorders, arrhythmia, congestive heart failure, diabetes, metabolic syndrome, known osteoporosis, depression, and chronic renal insufficiency.", 
                "measure": "Prevalence of Comorbidities", 
                "safety_issue": "No", 
                "time_frame": "Comorbidities captured at the index visit and related to 12 Months Prior to Study Index Visit"
            }, 
            {
                "measure": "Percentage of Participants having Annual Spirometric Tests", 
                "safety_issue": "No", 
                "time_frame": "12 months prior and up to the Study Index Visit"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02100332"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Takeda", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Takeda", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}